Oligella urethralis Bacteremia Associated with Urinary Tract Obstruction: A Case Report and Literature Review
Abstract
Oligella urethralis is a gram-negative, non-fermentative coccobacillus that is considered part of the normal urogenital flora but can cause opportunistic infections in immunocompromised patients or those with underlying conditions. Coccobacilli such as O. urethralis are rarely encountered as urinary pathogens compared to typical rod-shaped bacteria, making their identification clinically significant. We report a case of O. urethralis bacteremia in a 74-year-old male long-term care facility resident with ureteral stones who presented with acute pyelonephritis and bacteremia. Blood and urine cultures both yielded small gram-negative bacilli, which were identified as O. urethralis using MALDI-TOF mass spectrometry, and the patient was successfully treated with antibiotics. A literature search for reports published between 1987 and May 2025 identified six previously reported cases of O. urethralis bacteremia with English abstracts. Including our case, a total of seven cases were analyzed. All cases occurred in elderly patients (median age 79 years) with predisposing conditions, particularly obstructive uropathy. The prognosis was favorable; only one death occurred among the seven patients (1/7), and it was attributed to causes other than the O. urethralis infection. O. urethralis should be considered a potential pathogen in elderly patients with obstructive uropathy presenting with bacteremia, especially when gram-negative coccobacilli are identified on blood cultures.…
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Association of lower urinary tract symptoms and OAB severity with quality of life and mental health in China, Taiwan and South Korea: results from a cross-sectional, population-based study
- Ten-Day Quadruple Therapy Comprising Low-Dose Rabeprazole, Bismuth, Amoxicillin, and Tetracycline Is an Effective and Safe First-Line Treatment for Helicobacter pylori Infection in a Population with High Antibiotic Resistance: a Prospective, Multicenter, Randomized, Parallel-Controlled Clinical Trial in China
- The Role of the NLR and PLR in Urinary Tract Infection
- Threat of Antimicrobial Resistance among Pilgrims with Infectious Diseases during Hajj: Lessons Learnt from COVID-19 Pandemic
- Leclercia adecarboxylata urinary tract infection in a patient with bladder cancer and recurrent hematuria
- A Case Series of Staphylococcus lugdunensis Infection in Cancer Patients at an Academic Cancer Institute in the United States
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.